ArticleFrontiers in endocrinology2025
U-Shaped association between apolipoprotein A1 and serum uric acid levels in patients with osteoporotic fractures: a cross-sectional study.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lipid metabolism is closely linked to uric acid metabolism, with previous studies suggesting associations between lipid profiles to serum uric acid (SUA) levels. Apolipoprotein A1 (ApoA1), a key component in lipid metabolism and transport, may also be associated with SUA levels, though research in this area remains limited. This study aimed to investigate the independent association between ApoA1 levels and SUA in patients with osteoporotic fractures (OPF). Methods: This cross-sectional study included 2,108 OPF patients admitted to Kunshan Hospital, affiliated with Jiangsu University, from January 2017 to August 2023. Serum ApoA1 concentration was considered the exposure variable, and SUA concentration the outcome variable. Adjusted linear regression models and smooth curve fitting were employed to assess the relationship between ApoA1 and SUA. Nonlinear associations were examined using a generalized additive model (GAM), and a segmented regression method identified the inflection point. Univariate and stratified analyses were also performed. Results: Following adjustment for confounding covariates, a nonlinear relationship, U-shaped association was identified between serum ApoA1 and SUA concentrations, with an inflection point at 1.52 g/L. Estimated effects and 95% confidence intervals to the left and right of the inflection point were -55.20 (-75.57 to -34.82) and 77.33 (22.48 to 132.19), respectively. Conclusions: A U-shaped relationship between serum ApoA1 and SUA was identified in OPF patients. Based on these findings, we propose the concept of a "SUA trough" within the OPF population, additional research is required to explore the mechanism behind this association.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.